Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | EVP, Gen. Counsel & Secretary | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 119,024 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 48,076 · Balance 119,024 F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.
F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2023 Filed May 10, 2023 16:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 11,118 | $45.50 | $505,869.00 |
DisclosureSEC source: 0001209191-23-028505 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 07, 2023 Filed Feb 7, 2023 21:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,413 | $83.65 | $201,836.35 |
DisclosureSEC source: 0001209191-23-007699 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,374 F2 · price: The shares were sold in multiple transactions at prices ranging from $83.22 to $83.85, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-23-007699 · doc4.xml · derivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,118 Underlying: Class A Common Stock · 12,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was originally granted for a total of 52,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 12,000 | $85.00 | $1,020,000.00 |
DisclosureSEC source: 0001209191-23-007699 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,787 F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 12,000 | $45.50 | $546,000.00 |
DisclosureSEC source: 0001209191-23-007699 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 16:12 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,638 | $68.09 | $111,531.42 |
DisclosureSEC source: 0001209191-22-062429 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,787 F1 · balance_after: Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 332 | $70.44 | $23,387.41 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,425 F11 · price: The shares were sold in multiple transactions at prices ranging from $70.27 to $70.70, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F9 · balance_after: Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,738 | $69.80 | $330,722.35 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,757 F10 · price: The shares were sold in multiple transactions at prices ranging from $69.257 to $70.20, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F9 · balance_after: Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,612 | $70.80 | $114,129.60 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,495 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F9 · balance_after: Shares held following the reported transactions include 39,803 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 5,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · derivative · entry 11 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F14 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,600 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 5,344 PSUs. The remaining 1,256 PSUs were cancelled. F14 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,600 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 5,344 PSUs. The remaining 1,256 PSUs were cancelled. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,334 | $70.66 | $164,921.37 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,107 F8 · price: The shares were sold in multiple transactions at prices ranging from $70.433 to $71.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F7 · balance_after: Shares held following the reported transactions include 43,053 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 3,574 | $71.07 | $254,004.18 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,441 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F7 · balance_after: Shares held following the reported transactions include 43,053 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F5 · balance_after: Shares held following the reported transactions include 46,353 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 32,944 | $0.00 Strike: $71.07 | $0.00 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · derivative · entry 10 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,944 Underlying: Class A Common Stock · 32,944 shares Expires 2032-12-15 F13 · derivative.exercise_date: This option was granted for a total of 32,944 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 9,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · derivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,149 Underlying: Class A Common Stock · 9,149 shares Expires not disclosed F12 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F12 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F12 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 18,299 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,671 F4 · acquired: Award represents a total of 18,299 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2022. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F5 · balance_after: Shares held following the reported transactions include 46,353 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 2,510 | $73.17 | $183,656.70 |
DisclosureSEC source: 0001209191-22-062075 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,372 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F2 · balance_after: Shares held following the reported transactions include 28,054 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 281 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2022. Read SEC document |
| February 09, 2022 Filed Feb 9, 2022 20:36 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,798 | $77.23 | $138,859.54 |
DisclosureSEC source: 0001209191-22-008259 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,601 F1 · balance_after: Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 20, 2021 Filed Dec 20, 2021 20:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,638 | $90.69 | $148,550.22 |
DisclosureSEC source: 0001209191-21-070706 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,399 F2 · balance_after: Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 20:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,663 | $90.17 | $149,952.71 |
DisclosureSEC source: 0001209191-21-070706 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,037 F2 · balance_after: Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 20:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,612 | $92.00 | $148,304.00 |
DisclosureSEC source: 0001209191-21-070706 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,700 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 35,311 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,545 | $0.00 Strike: $91.80 | $0.00 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,545 Underlying: Class A Common Stock · 30,545 shares Expires 2031-12-15 F10 · derivative.exercise_date: This option was granted for a total of 30,545 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2021, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 7,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,378 Underlying: Class A Common Stock · 7,378 shares Expires not disclosed F9 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F9 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 14,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,713 F4 · acquired: Award represents a total of 14,757 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2021. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F5 · balance_after: Shares held following the reported transactions include 41,861 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 3,506 | $90.55 | $317,468.30 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,956 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 27,104 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 452 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:12 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-21-016831 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,118 Underlying: Class A Common Stock · 13,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:12 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 13,000 | $100.00 | $1,300,000.00 |
DisclosureSEC source: 0001209191-21-016831 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010 F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 16:12 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 13,000 | $45.50 | $591,500.00 |
DisclosureSEC source: 0001209191-21-016831 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 16:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-21-011290 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,118 Underlying: Class A Common Stock · 13,000 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 16:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 13,000 | $95.00 | $1,235,000.00 |
DisclosureSEC source: 0001209191-21-011290 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010 F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 16:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 13,000 | $45.50 | $591,500.00 |
DisclosureSEC source: 0001209191-21-011290 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,118 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · derivative · entry 10 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 23,118 shares Expires 2023-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This performance-based stock option award was granted for a total of 26,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 24,700 shares. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,882 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · derivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,118 Underlying: Class A Common Stock · 2,882 shares Expires 2026-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 496 | $92.23 | $45,746.08 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010 F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 22,622 | $91.58 | $2,071,718.24 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,506 F4 · price: The shares were sold in multiple transactions at prices ranging from $91.135 to $92.08, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 23,118 | $45.50 | $1,051,869.00 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 175 | $92.23 | $16,140.25 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010 F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,707 | $91.48 | $247,635.28 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,185 F3 · price: The shares were sold in multiple transactions at prices ranging from $91.17 to $92.08, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,882 | $45.50 | $131,131.00 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,892 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 227 | $92.23 | $20,936.21 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,010 F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 21:19 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,436 | $91.68 | $131,648.75 |
DisclosureSEC source: 0001209191-21-008662 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,237 F1 · price: The shares were sold in multiple transactions at prices ranging from $91.22 to $91.94, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 34,172 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 17:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,638 | $91.96 | $150,629.50 |
DisclosureSEC source: 0001209191-20-064695 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,673 F3 · price: The shares were sold in multiple transactions at prices ranging from $91.66 to $92.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 34,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 17:51 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,612 | $91.03 | $146,740.36 |
DisclosureSEC source: 0001209191-20-064695 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,311 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 34,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 337 | $91.66 | $30,888.00 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,923 F7 · price: The shares were sold in multiple transactions at prices ranging from $91.42 to $92, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · balance_after: Shares held following the reported transactions include 37,422 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 3,065 | $90.62 | $277,748.46 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,260 F6 · price: The shares were sold in multiple transactions at prices ranging from $90.147 to $91.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F5 · balance_after: Shares held following the reported transactions include 37,422 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,637 | $92.08 | $150,734.96 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,325 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F5 · balance_after: Shares held following the reported transactions include 37,422 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 332 | $91.90 | $30,511.60 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,312 F8 · price: The shares were sold in multiple transactions at prices ranging from $91.81 to $92.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F6 · balance_after: Shares held following the reported transactions include 38,561 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,432 | $90.97 | $130,263.17 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,644 F7 · price: The shares were sold in multiple transactions at prices ranging from $90.65 to $91.35, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F6 · balance_after: Shares held following the reported transactions include 38,561 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2020 Filed Dec 16, 2021 21:25 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,637 | $91.80 | $150,276.60 |
DisclosureSEC source: 0001209191-21-070104 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,076 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 38,561 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 19:27 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,553 | $0.00 Strike: $92.08 | $0.00 |
DisclosureSEC source: 0001209191-20-064236 · doc4.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,553 Underlying: Class A Common Stock · 30,553 shares Expires 2030-12-15 F9 · derivative.exercise_date: This option was granted for a total of 30,553 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2020, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.